Home > Boards > US OTC > Medical - Drugs > Innovation Pharmaceuticals Inc. (IPIX)

B has recently been mentioned as an aerosol.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
farrell90 Member Profile
Member Level 
Followed By 100
Posts 3,008
Boards Moderated 0
Alias Born 01/28/06
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2020 5:28:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/26/2020 2:16:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/21/2020 9:33:35 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2020 9:03:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/28/2020 9:30:58 AM
Cannabis and CBD Stocks are Old News, The Next Hot Peripheral Sector is Here! InvestorsHub NewsWire - 4/16/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/6/2020 2:21:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/1/2020 4:39:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2020 12:00:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/6/2020 12:01:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/27/2020 12:01:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/13/2020 4:06:02 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/13/2020 4:02:49 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 12/26/2019 5:19:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/26/2019 5:16:58 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 12/16/2019 8:32:20 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/13/2019 9:24:21 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/22/2019 6:01:03 AM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 10/17/2019 5:24:36 PM
Annual Report (10-k) Edgar (US Regulatory) - 9/30/2019 4:38:42 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 9/20/2019 4:36:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/20/2019 4:34:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/6/2019 4:52:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/6/2019 4:51:57 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 8/13/2019 4:11:11 PM
farrell90 Member Level  Saturday, 05/23/20 06:22:05 PM
Re: JPsooner post# 298422
Post # of 308032 
B has recently been mentioned as an aerosol.

"Additional drug delivery development work (e.g.,intranasal/nebulizeddosing, the use of nanotechnologies8) may further complement Brilacidin’s anti-COVID-19 therapeutic potential"

http://www.ipharminc.com/brilacidin-1 pg 19

Due to the immunomodulating abilities of B it has been mentioned as a treatment for Asthma and Copd even back in the Polymedix days. IPIX has infrequently mentioned B as an inhaler recently as a treatment for pulmonary disorders.In the Brilacidin for covid 19 pdf, IPIX affirms an aerosol is a possible area for future study. I am not aware of any current plans to develop an aerosol at this time


10% of the Covid pt have GI complaints so I guess it could b given as a treatment for gastroenteritis.


B is not absorbed systemically so it is unlikely a pill would be effective.

Good luck,Farrell


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist